KMB
USDKimberly-Clark Corporation Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$103.850
Максимум
$103.870
Минимум
$101.610
Объем
12.41M
Фундаментальные показатели компании
Рыночная капитализация
34.1B
Отрасль
Household & Personal Products
Страна
United States
Статистические данные торговли
Средний объем
3.53M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
TD Cowen Maintains Hold on Kimberly-Clark, Lowers Price Target to $112
TD Cowen analyst Robert Moskow maintains Kimberly-Clark with a Hold and lowers the price target from $130 to $112.
Morgan Stanley Maintains Equal-Weight on Kimberly-Clark, Lowers Price Target to $125
Morgan Stanley analyst Dara Mohsenian maintains Kimberly-Clark with a Equal-Weight and lowers the price target from $144 to $125.
Wells Fargo Maintains Equal-Weight on Kimberly-Clark, Lowers Price Target to $110
Wells Fargo analyst Chris Carey maintains Kimberly-Clark with a Equal-Weight and lowers the price target from $129 to $110.
Palantir earnings, Pizza Hut's options, a new consumer staples giant and more in Morning Squawk
Here are five key things investors need to know to start the trading day.
Evercore ISI Group Downgrades Kimberly-Clark to In-Line, Lowers Price Target to $120
Evercore ISI Group analyst Javier Escalante downgrades Kimberly-Clark from Outperform to In-Line and lowers the price target from $150 to $120.
Kimberly-Clark CEO talks Kenvue acquisition, calls Tylenol brand 'resilient'
Kimberly-Clark CEO Mike Hsu discussed his company's $48.7 billion acquisition of Kenvue in a Monday interview with CNBC's Jim Cramer.
Kenvue’s legal risks loom over planned acquisition by Kimberly-Clark
Kimberly-Clark said on Monday it plans to acquire Band-Aid maker Kenvue , even as the latter company faces thousands of lawsuits involving its painkiller Tylenol and talc-based baby powder, raising questions about the scope of the liabilities Kimberly-Clark might inherit.
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.